Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas ...Middle East

PR Newswire - News
Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas
HOUSTON, Dec. 29, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that the US Food and Drug...

Read More Details
Finally We wish PressBee provided you with enough information of ( Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas )

Apple Storegoogle play

Also on site :